Align Technology stock (US0162551016): Beats Q1 estimates with EPS $2.58, revenue up 6.2%

Align Technology released its latest quarterly results, surpassing analyst expectations. Earnings per share came in at $2.58, topping the consensus estimate of $2.26, while revenue reached $1.04 billion, reflecting 6.2% growth from the prior year, according to MarketBeat as of 05/13/2026.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Align Technology: core business model

Align Technology leads the market in clear aligner therapy, primarily through its Invisalign system. The company designs, manufactures, and sells custom orthodontic devices using proprietary software and 3D printing technology. This model allows for direct-to-consumer digital treatment planning via the ClinCheck platform, serving orthodontists and general dentists worldwide. In the US, where a significant portion of revenue is generated, Align benefits from high adoption rates in aesthetic dentistry.

The business operates on a consumables-driven model, with recurring sales from aligner trays and scanners. This provides visibility into future revenue streams, as patients typically require multiple sets over 12-24 month treatments. Align's iTero intraoral scanners complement the ecosystem by enabling digital impressions, reducing reliance on traditional molds.

Main revenue and product drivers for Align Technology

Clear aligners account for the majority of revenue, with Invisalign teen and adult segments driving growth. Recent quarters show strength in cases started, a leading indicator for aligner shipments. The Q1 2026 results highlighted $1.04 billion in revenue, up 6.2% year-over-year, per the MarketBeat report dated 05/13/2026. Scanner sales and services add high-margin recurring income through software subscriptions and recurring fees.

Geographically, North America remains the largest market, contributing over 50% of sales due to favorable reimbursement and consumer demand for discreet orthodontics. International expansion, particularly in EMEA and APAC, supports diversification. Key drivers include volume growth in teen treatments and premium products like Invisalign Go for mild cases.

Industry trends and competitive position

The orthodontics market is shifting toward digital and clear alternatives, with Align Technology holding over 80% global share in clear aligners. Competitors like SmileDirectClub have faced challenges, strengthening Align's moat. US investors note the company's exposure to rising aesthetic dentistry demand, projected to grow amid aging populations and millennial orthodontics.

Why Align Technology matters for US investors

Listed on Nasdaq under ALGN, Align Technology offers US investors direct access to the $10+ billion orthodontics sector. Its dominant position and recurring revenue model provide stability amid healthcare volatility. With strong US market penetration, the stock reflects broader trends in elective dental procedures, relevant for portfolios seeking medtech growth.

Conclusion

Align Technology's Q1 beat underscores resilient demand for its Invisalign system amid competitive pressures. With EPS and revenue exceeding forecasts, the company maintains momentum in clear aligner leadership. Investors track case starts and international growth for ongoing performance insights.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.